C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 471/04 (2006.01) A61K 31/47 (2006.01) A61K 31/495 (2006.01) A61K 31/535 (2006.01) A61K 31/55 (2006.01) C07D 215/18 (2006.01) C07D 215/233 (2006.01) C07D 215/42 (2006.01) C07D 405/12 (2006.01) C07D 475/00 (2006.01) C07D 475/02 (2006.01) C07D 498/04 (2006.01) C07D 513/04 (2006.01)
Patent
CA 2263913
This invention relates to compounds of formula (I), wherein A, B, D, E, K, G, R3 and R5 are defined as in the specification, and to the pharmaceutically acceptable salts of such compounds. Compounds (I) are corticotropin releasing factor (hormone) CRF (CRH) antagonists.
Composés de formule (I) et sels pharmaceutiquement acceptables de ces derniers. Ces composés (I) sont des antagonistes du facteur (hormone) libérant de la corticotropine (FLC) (HLC). Dans la formule (I) A, B, D, E, K, G, R<3> et R<5> sont tels que définis dans la description de la demande de brevet.
Pfizer Inc.
Smart & Biggar
LandOfFree
Substituted 6,6-hetero-bicyclic derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted 6,6-hetero-bicyclic derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 6,6-hetero-bicyclic derivatives will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1932703